☆ 4.5 Article

COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs

RMD OPEN (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

Steven R. Ytterberg et al.

Summary: In this trial comparing the use of tofacitinib with a TNF inhibitor in a cardiovascular risk-enriched population, the risks of major adverse cardiovascular events (MACE) and cancers were found to be higher with tofacitinib, and it did not meet noninferiority criteria. Several adverse events were more common with tofacitinib.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Psychiatry

Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021

Lindsey Wang et al.

Summary: The study found that individuals with substance use disorders (SUDs) have a significantly higher risk of breakthrough COVID-19 infection after vaccination compared to those without SUDs, particularly for patients with cocaine and cannabis use disorders. When controlling for lifetime comorbidities and adverse socioeconomic determinants of health, the risk for breakthrough infection in SUD patients is no longer significantly different from non-SUD individuals, except for those with cannabis use disorder who remain at increased risk.

WORLD PSYCHIATRY (2022)

添加到收藏夹

Article Rheumatology

COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis

Rene Cordtz et al.

Summary: The study aimed to investigate the COVID-19 hospitalization incidence in unvaccinated and vaccinated patients with RA compared to controls. Results showed higher rates of COVID-19 hospitalization in both unvaccinated and vaccinated RA patients compared to controls, but a decrease in relative risk for RA patients after vaccination suggests a comparable benefit in most patients.

RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

Outcomes of coronavirus disease 19 patients with a history of rheumatoid arthritis: A retrospective registry-based study in Iran

Mahsa Zargaran et al.

Summary: This study examined the outcomes of COVID-19 in RA patients in Iran and found that RA patients have a higher risk and mortality rate compared to non-RA patients. This risk is particularly elevated in RA patients receiving low-dose prednisolone therapy.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2022)

添加到收藏夹

Article Rheumatology

Covid-19 vaccination in autoimmune rheumatic diseases: A multi-center survey from southern India

Kavitha Mohanasundaram et al.

Summary: This survey evaluated the COVID-19 vaccination status in patients with autoimmune rheumatic diseases. The majority of patients received ChAdOx1 nCov-19 and BBV 152 vaccines, which were found to be safe. Vaccine hesitancy was mainly due to fear of side effects. A small subset of patients experienced breakthrough infections and disease flares after vaccination.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2022)

添加到收藏夹

Letter Medicine, General & Internal

Response to: 'Concerns about 'Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks' by Renin Chang et al

Weijie Wang et al.

ECLINICALMEDICINE (2022)

添加到收藏夹

Article Rheumatology

TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case-Control Study

Mansour Salesi et al.

Summary: The study examined the role of TNF-alpha blockers in preventing COVID-19 incidence in patients with rheumatoid arthritis or seronegative spondyloarthropathies. Results showed that patients treated with TNF-alpha blockers had a lower percentage of COVID-19 cases compared to those not receiving TNF-alpha blockers.

RHEUMATOLOGY AND THERAPY (2021)

添加到收藏夹

Article Medicine, General & Internal

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Shruti Gupta et al.

Summary: A multicenter cohort study found that early treatment with tocilizumab may reduce mortality among critically ill patients with COVID-19. Further research from randomized clinical trials is needed to confirm these findings.

JAMA INTERNAL MEDICINE (2021)

添加到收藏夹

Article Rheumatology

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3

Ted R. Mikuls et al.

Summary: Guidance on managing adult rheumatic disease during the COVID-19 pandemic was developed by a task force of rheumatologists and infectious disease specialists. Through collating clinical questions, generating an evidence report, and using a modified Delphi process, final guidance statements were approved and presented as a living document due to the rapidly evolving literature and low level of available evidence. These statements aim to promote optimal care during the current pandemic with updates anticipated in the future.

ARTHRITIS & RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic

Lai-Shan Tam et al.

Summary: The APLAR updated guidelines on managing rheumatic and musculoskeletal diseases during the COVID-19 pandemic. Research focused on diagnosis and treatment of adult RMD patients, with consensus reached on key aspects of COVID-19 screening, management of RMD patients with and without confirmed COVID-19, medication adjustments, telemedicine, vaccination, and the impact of the pandemic on quality of life and treatment adherence.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)

添加到收藏夹

Review Cell Biology

COVID-19 and Rheumatoid Arthritis Crosstalk: Emerging Association, Therapeutic Options and Challenges

Saikat Dewanjee et al.

Summary: This article highlights the pathological crosstalk between COVID-19 and RA, emphasizing the importance of immune responses, particularly in the activation of cytokines. It also points out the relevance of the relationship between COVID-19 and RA for clinical monitoring and management.

CELLS (2021)

添加到收藏夹

Article Rheumatology

Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study

Youn Ho Shin et al.

Summary: In the early stages of the COVID-19 pandemic, autoimmune inflammatory rheumatic diseases were linked to a higher likelihood of testing positive for SARS-CoV-2, experiencing more severe COVID-19 outcomes, and facing COVID-19-related deaths in South Korea. High doses of systemic corticosteroids, but not DMARDs, were associated with negative effects on SARS-CoV-2 infection and COVID-19 clinical outcomes.

LANCET RHEUMATOLOGY (2021)

添加到收藏夹

Meeting Abstract Rheumatology

COMPARISON OF SELF-INJECTION DEVICES FOR ADMINISTERING ANTI-TUMOR NECROSIS FACTOR AGENTS USING THE ORIGINAL QUESTIONNAIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS

Y. Hirano et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Review Critical Care Medicine

Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials

Timothy Arthur Chandos Snow et al.

Summary: For hospitalized COVID-19 patients, there is some evidence that tocilizumab use may be associated with a short-term mortality benefit, but further high-quality data are required. Its benefits may also lie in reducing the need for mechanical ventilation.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Morris J. Brown et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Rheumatology

Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study

April Jorge et al.

Summary: Severe COVID-19 outcomes have shown improvement over time for patients with rheumatic and musculoskeletal diseases, indicating potential progress in treatment and supportive care.

LANCET RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Milena Gianfrancesco et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

添加到收藏夹

Article Rheumatology

COVID-19 revisiting inflammatory pathways of arthritis

Georg Schett et al.

NATURE REVIEWS RHEUMATOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

Stephanie L. Harrison et al.

PLOS MEDICINE (2020)

添加到收藏夹

Review Health Care Sciences & Services

Criteria for use of composite end points for competing risks-a systematic survey of the literature with recommendations

Veena Manja et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.